PROK1 expression decreased with elevated Gleason scores, tumor grade, and BCR status, suggesting that the progression of PCa may be related to the inhibition of PROK1's oncogenic effect (Fig. 9M-Q). This evidence concerns the gene BCR and neoplasm.